Veracyte Inc VCYT:NASDAQ

Last Price$25.96NASDAQ Previous Close - Last Trade as of 4:00PM ET 11/19/19

Today's Change+0.52(2.04%)
Bid (Size)$25.94 (6)
Ask (Size)$25.94 (56)
Day Low / High$25.28 - 26.44
Volume414.0 K
  • Latest Stories
  • Commentary and Analysis
Veracyte Q3 Results Beat Expectations
5:07PM ET 10/22/2019 MT Newswires

Veracyte (VCYT) on Tuesday reported a $0.02 loss per share for Q3, down from $0.12 loss per share in the year-ago period, beating Capital IQ estimate of...

Veracyte's Noninvasive Nasal Swab Test Shows Accurate Classification of Lung Cancer Risk in Patients With Lung Nodules
3:15PM ET 10/22/2019 MT Newswires

Veracyte (VCYT) said Tuesday its noninvasive nasal swab test's preliminary clinical data showed an accurate classification of lung cancer risk in patients...

MT Newswires After-Hours News Movers
5:54PM ET 10/21/2019 MT Newswires

Some of the stocks moving on news-driven events in Monday's after-hours include: NLNK, +7.38% AMTD, +5.31% CDNS, +4.84% WSFS, +1.79% UPS, +1.58% ZION,...

Veracyte's Data Shows Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis
5:11PM ET 10/21/2019 MT Newswires

Veracyte (VCYT) said on Monday data showed the clinical validity of its next-generation Percepta Genomic Sequencing Classifier (GSC) and the clinical...

Insider Trends: Insider at Veracyte Converts Options in Mist of 90-Day Buying Trend
4:08PM ET 9/20/2019 MT Newswires

On Sep 18, 2019, Keith Kennedy, COO / CFO, exercised options for 22,365 shares in Veracyte (VCYT) for $167,067. Kennedy, subsequent to the transactions...

Insider Trends: Veracyte Insider Extends 90-Day Selling Trend
5:47PM ET 9/12/2019 MT Newswires

Bonnie H Anderson, Director and Chairman & CEO, sold 8,000 shares of Veracyte (VCYT) on Sep 10, 2019, for $196,114. Subsequent to the Form 4 filing with...

::C22310FF-6260-40DE-80A4-4FE49D389E51}} Time 9/5/2019 5:24:24 PM File did not print ref HEADLINEACTION.16 FTMUM 16 CODE FMS
5:25PM ET 9/05/2019 MT Newswires

File did not print ref INSIDERACTIVITY.16 FTMUM 16 CODE FMS Dr Kennedy, following the transactions disclosed in the Form 4 SEC filing, owns 47,449 company...

Insider Trends: Veracyte Insider Sale Scales Back 90-Days of Buys
4:34PM ET 8/29/2019 MT Newswires

On Aug 27, 2019, Director, Evan Jones, executed a sale of 10,000 shares in Veracyte (VCYT) for $261,051. Jones has control over 204,653 company shares of...

Insider Trends: Veracyte Sees 90 Days of Insider Buying Trend Slowing with Share Sale
4:26PM ET 8/12/2019 MT Newswires

Evan Jones, Director, sold 15,000 shares of Veracyte (VCYT) on Aug 09, 2019, for $395,681. Following the Form 4 filing with the SEC, Jones controls a...

Insider Trends: Insider at Veracyte Converts Options in Mist of 90-Day Buying Trend
4:20PM ET 8/05/2019 MT Newswires

Fred E Cohen, Director, exercised options for 40,000 shares in Veracyte (VCYT) for $368,200 on Aug 02, 2019. Cohen, following the transactions detailed in...